Exogenous peptide and protein expression levels using retroviral vectors in human cells

Molecular Therapy

Volumn 4, Issue 5, 2001, Pages 398-406

  Sandrock, Tanya M ^a   Risley, Bob ^a   Richards, Burt T ^a   Poritz, Mark A ^a   Austin, Harry A ^a   Yoo, Sanghee ^a   Kim, Marianne K H ^a   Roth, Bruce ^a   Repetny, Karen ^a   Hsu, Forrest ^a   Stump, Mark ^a   Teng, David H F ^a   Kamb, Alexander ^a  

^a Deltagen Proteomics Incorporated   (United States)

Author keywords

Cell line; Concentration; E7; Peptide; Retinoblastoma; Retroviral; Transdominant

Indexed keywords

AMINO ACID; APOLIPOPROTEIN E7; GREEN FLUORESCENT PROTEIN; PEPTIDE; VIRUS PROTEIN; VIRUS VECTOR;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TARGETING; HOST CELL; HUMAN; HUMAN CELL; PENETRANCE; PHENOTYPE; PROTEIN EXPRESSION; RETROVIRUS; WART VIRUS;

HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS TYPES; MAMMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0035184471     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0476     Document Type: Article

References (34)

1. MaRX: An approach to genetics in mammalian cells
2. Transdominant genetics, peptide inhibitors and drug targets
3. Dominant effector genetics in mammalian cells
4. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: Implications for gene therapy
5. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
6. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
7. Protein tags enhance GFP folding in eukaryotic cells
8. Rapid protein-folding assay using green fluorescent protein
9. In vivo half-life of a protein is a function of its amino-terminal residue
10. Universality and structure of the N-end rule
11. Carboxy-terminal determinants of intracellular protein degradation
12. Green fluorescent protein as a scaffold for intracellular presentation of peptides
13. The use of percent volume analysis in Coulter sizing of cells in gynecologic cytopathologic cell suspensions
14. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein
15. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
16. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells
17. Reversible, p16-mediated cell cycle arrest as protection from chemotherapy
18. Gene therapy: The need for basic science
19. Peptide inhibitors expressed in vivo
20. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal
21. Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA
22. Cloning mammalian genes by expression selection of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization
23. Identification of p53 genetic suppressor elements which confer resistance to cisplatin
24. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity
25. An artificial cell-cycle inhibitor isolated from a combinatorial library
26. Retroviral delivery of peptide modulators of cellular functions
27. Protein-peptide interactions analyzed with the yeast two-hybrid system
28. FACS-optimized mutants of the green fluorescent protein (GFP)
29. Variability of transcriptional regulation after gene transfer with the retroviral tetracycline system
30. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site
31. Attenuation of green fluorescent protein half-life in mammalian cells
32. High-efficiency transformation of mammalian cells by plasmid DNA